Tag: APIs

March 20, 2018

Millennial Esports’ Eden Games Amongst First Studios to Integrate Amazon GameOn

Millennial Esports Corp. ("Millennial" or the "Company") (TSXV:GAME) (OTCQB:MLLLF), a mobile video game publisher focused on Esports and Racing, today...
March 1, 2018

Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido

Sorrento Therapeutics (NASDAQ:SRNE) and its majority-owned subsidiary, Scilex Pharmaceuticals, received approval from the U.S. Food and Drug Administration (FDA) for...
February 21, 2018

Net Element Joins the Enterprise Ethereum Alliance

Net Element (NASDAQ:NETE) has announced it has joined the Enterprise Ethereum Alliance, the world’s largest open-source blockchain initiative with over...
February 8, 2018

Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results

Cambrex (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reports results for the fourth quarter...
January 30, 2018

Cambrex Expands Process Research and Development Capabilities Across North America

Cambrex (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced an investment to...
January 11, 2018

Lexaria Featured on NetworkNewsWire Nicotine Delivery Methods Article

Lexaria Bioscience (CSE:LXX,OTCQB:LXRP) was featured in a NetworkNewsWire article regarding alternatives to smoking cigarettes as a nicotine delivery method.
December 13, 2017

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces the United States...